Bitterman Kevin

Insider Buys Quantity –
1
2021-06-01SaleAkero Therapeutics, Inc.
AKRO
director
945
0.0027%
$26.28$24,835-20.02%
2020-10-09SaleAkero Therapeutics, Inc.
AKRO
director
26,000
0.0753%
$28.93$752,180-3.99%
2019-06-24PurchaseAkero Therapeutics, Inc.
AKRO
director
540,000
13.8839%
$16.00$8.64M+13.18%
2017-05-22SaleEditas Medicine, Inc.
EDIT
director
2M
4.772%
$17.00$34M+43.15%
2016-12-07SaleEditas Medicine, Inc.
EDIT
150,000
0.4203%
$15.82$2.37M+22.88%
2016-12-06SaleEditas Medicine, Inc.
EDIT
100,000
0.2779%
$15.87$1.59M+21.09%
2016-12-05SaleEditas Medicine, Inc.
EDIT
160,000
0.4472%
$15.74$2.52M+22.34%
2016-11-23SaleEditas Medicine, Inc.
EDIT
42,960
0.1205%
$15.71$674,902+20.98%
2016-11-22SaleEditas Medicine, Inc.
EDIT
25,638
0.0719%
$15.77$404,311+20.25%
2016-11-16SaleEditas Medicine, Inc.
EDIT
61,660
0.1803%
$16.30$1.01M+20.61%
2016-11-15SaleEditas Medicine, Inc.
EDIT
61,730
0.1736%
$16.57$1.02M+13.89%
2016-11-14SaleEditas Medicine, Inc.
EDIT
116,070
0.3279%
$17.16$1.99M+10.29%
2016-09-08SaleEditas Medicine, Inc.
EDIT
1M
2.7494%
$16.80$16.8M+1.57%